Adaptive hypersensitivity to estrogen: Mechanisms and clinical relevance to aromatase inhibitor therapy in breast cancer treatment
- 1 May 2005
- journal article
- review article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 95 (1-5) , 155-165
- https://doi.org/10.1016/j.jsbmb.2005.04.025
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Long-Term Exposure to Tamoxifen Induces Hypersensitivity to EstradiolClinical Cancer Research, 2004
- Activation of the MAPK Pathway Enhances Sensitivity of MCF-7 Breast Cancer Cells to the Mitogenic Effect of EstradiolEndocrinology, 2002
- Estrogenic impurities in labwareNature Biotechnology, 2001
- Role of MAP kinase in the enhanced cell proliferation of long term estrogen deprived human breast cancer cellsBreast Cancer Research and Treatment, 2000
- Estradiol Hypersensitivity and Mitogen-Activated Protein Kinase Expression in Long-Term Estrogen Deprived Human Breast Cancer Cells in VivoEndocrinology, 2000
- Estrogen Receptor Expression and Function in Long-Term Estrogen-Deprived Human Breast Cancer CellsEndocrinology, 1998
- Long-term tamoxifen therapy: can an antagonist become an agonist?Journal of Clinical Endocrinology & Metabolism, 1996
- Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cellsJournal of Clinical Endocrinology & Metabolism, 1995
- The Effects of a Constitutive Expression of Transforming Growth Factor-α on the Growth of MCF-7 Human Breast Cancer Cellsin Vitroandin VivoMolecular Endocrinology, 1989
- Adaptation of estrogen-dependent MCF-7 cells to low estrogen (phenol red-free) cultureEuropean Journal of Cancer and Clinical Oncology, 1987